Provide Commercial strategic consulting services focusing on cell and gene therapies for treatment of rare diseases.

Develop and lead CARVYKTI Global Commercial strategy and launch execution activities for the treatment of relapsed or refractory multiple myeloma
• Led most successful global Commercial launch for a cell therapy
• Serve on Global Joint Steering Committee with Janssen on all co-development activities
• Perform life-cycle opportunity assessment, product positioning and brand development strategies
• Align market access, pricing/reimbursement and value proposition strategy and execution
• Create cell therapy operational model starting from patient identification through product fulfillment Clinical Development Pipeline
• Serve as Executive Committee member for all go/no go pipeline decisions
• Create portfolio optimization strategy and new product valuation models
• Evaluate clinical/discovery in-license/out-license opportunities in support of corporate development plan Business Development
• Serve as Executive Committee member for Commercial go/no-go decisions for all in/out-lic

Develop commercial development strategy and corresponding launch plan for bb2121 in the treatment Multiple Myeloma. Responsibilities included:
• Lead co-promote agreement with bb2121 partner Bluebird Bio
• Perform market opportunity assessment, product positioning and brand development
• Obtain cross-functional alignment on go to market model across Multiple Myeloma franchise
• Drive market access, pricing/reimbursement and value proposition strategy

Lead development and implementation of US Commercial Strategy function for commercialized and pipeline assets in the Hematology/Oncology product portfolio.

Lead Marketing direction and oversight for $1.1B+ VELCADE brand to include planning, market assessment, pricing strategies and promotion. Responsible for translating overall brand strategy into tactical planning and execution plans to achieve profitability objectives.

Establish new global Oncology informatics and consulting franchise of $135M, through the sales and maintenance of Portfolio Planning, Strategic Marketing Assessments, and Commercial Effectiveness engagements. Geographic areas of responsibility include the Americas, Europe, Japan and Asia Pacific regions.

Created and implemented global commercial development strategies for newly formed Innovation Business Unit. Lead Executive Steering Committee decisions on Oncology product development strategies, forecasts and development schedules.

Created, organized and led all product launch activities for a start-up Specialty, hospital sales organization. Activities included GPO/CMS Contracting Strategy, Sales Operations, Training & Development, Pricing & Market Access strategy and Trade & Distribution

Exceeded MCO/PBM sales targets of $2.3B for Johnson & Johnson's largest pharmaceutical organization. Managed contract pull/push contracting strategies for Managed Care, Pharmacy Benefit, and State Medicaid business segments.

Manage first line sales leaders and staff to drive sales performance.